Form 144 TEVA PHARMACEUTICAL INDUSTRIES LTD For: 4 May

H.C. Wainwright cuts Longeveron stock price target on dilution

Investing.com · News 11m ago

Vanda launches motion sickness drug after 40-year gap

Investing.com · News 11m ago

BMO reiterates FMC stock rating on 2026 guidance, asset sale plans

Investing.com · News 11m ago

Devil Wears Prada 2 opens with $77M at domestic box office

Investing.com · News 11m ago

Nvidia Is Up 7% in 2026 While Marvell Technology Has Nearly Doubled. Here's Why.

Motley Fool · Finance 12m ago

BMO Capital reiterates Bristol-Myers Squibb stock rating at Market Perform

Investing.com · News 12m ago

Stifel reiterates Klaviyo stock rating on platform evolution

Investing.com · News 12m ago

EU nations seek quick US trade deal to prevent car tariff increase

Investing.com · News 14m ago

HSBC lowers AMD to Hold ahead of earnings on limited upside potential

Investing.com · Investing_news 15m ago

DBS Group Holdings added to Morgan Stanley Asia ex-Japan focus list

Investing.com · News 16m ago